FDA approves Aspire Cristalle for Mammography Imaging-Fujifilm

Fujifilm Medical Systems USA, has announced it has received 510(k) clearance from the FDA of the Aspire Cristalle imaging system for Mammography. The Aspire Cristalle uses a new hexagonal close pattern detector pixel design which is engineered to deliver higher acquisition efficiency, finer detail, higher DQE, higher MTF and lower dose than conventional square pixel arrays. It also uses Fujifilm�s iAEC automated exposure controls and ISC precisely tuned contrast to intelligently adapt to the specific characteristics for every breast type.